コンテンツへスキップ
Merck

Selective Modulation of the Keratoconic Stromal Microenvironment by FSH and LH.

The American journal of pathology (2023-02-24)
Paulina Escandon, Sarah E Nicholas, Brenda Vasini, Rebecca L Cunningham, David A Murphy, Kamran M Riaz, Dimitrios Karamichos
要旨

Keratoconus (KC) affects the corneal structure, with thinning and bulging outward into a conelike shape. Irregular astigmatism and decreased visual acuity appear during puberty and progress into the mid-30s, with unpredictable disease severity. The cause of KC is recognized as multifactorial, but remains poorly understood. Hormone imbalances are a significant modulator of the onset of KC. This study sought to investigate the role of gonadotropins, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) in KC, using a three-dimensional, self-assembled matrix in vitro model. Healthy corneal fibroblasts and human KC cells in the corneal stroma were isolated, cultured, and stimulated with stable vitamin C to promote extracellular matrix assembly. Cultures were further stimulated with 2.5 or 10 mIU/mL FSH and 5 or 35 mIU/mL LH. Samples were evaluated for cell proliferation and morphology via BrdU assay and imaging; protein expression was assessed via Western blot analysis. Proliferation was significantly greater in human KC cells compared to healthy corneal fibroblasts with LH stimulation, but no changes were found with FSH stimulation. Additionally, in sex hormone receptors, fibrotic markers, proteoglycans, and members of the gonadotropin signaling pathway were significantly changed, largely driven by exogenous LH. The impact of exogenous FSH/LH in the KC stromal microenvironment was demonstrated. These results highlight the need to further examine the role of FSH/LH in KC and in human corneal homeostasis.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
Anti-Cellular Fibronectin antibody, Mouse monoclonal, clone FN-3E2, hybridoma cell culture supernatant
Sigma-Aldrich
抗CAMP抗体 マウス宿主抗体, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-CRH antibody produced in mouse, purified immunoglobulin, buffered aqueous solution